WT1 overexpression at diagnosis may predict favorable outcome in patients withde novonon-M3 acute myeloid leukemia-Reference-Cited by-同舟云学术

WT1 overexpression at diagnosis may predict favorable outcome in patients withde novonon-M3 acute myeloid leukemia

Published:2011-09-23 Issue:10 Volume:52 Page:1961-1969
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Miglino Maurizio,Colombo Nicoletta,Pica Gianmatteo,Grasso Raffaella,Clavio Marino,Bergamaschi Micaela,Ballerini Filippo,Ghiso Anna,Ghiggi Chiara,Mitscheunig Laura,Beltrami Germana,Cagnetta Antonia,Vignolo Luana,Lucchetti Maria Vita,Aquino Sara,Pierri Ivana,Sessarego Mario,Carella Angelo Michele,Gobbi Marco

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2011.585673

Reference48 articles.

1. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials

2. Monitoring of minimal residual disease in patients with core binding factor acute myeloid leukemia and the impact ofC-KIT,FLT3, andJAK2mutations on clinical outcome

3. Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia

4. BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML)

5. Insertion of FLT3 internal tandem duplication in the tyrosine kinase domain-1 is associated with resistance to chemotherapy and inferior outcome

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. WT1 together with RUNX1::RUNX1T1 targets DUSP6 to dampen ERK activity in acute myeloid leukaemia;British Journal of Haematology;2024-08-27

2. High WT1 expression predicted induction chemotherapy failure in acute myeloid leukemia patients with non-favorable cytogenetic risk;Clinical and Experimental Medicine;2023-01-13

3. FLT3-ITD Mutation and FLT3 Ligand Plasma Level Were Not Associated with One-Year Survival of Indonesian Acute Myeloid Leukemia Patients;OncoTargets and Therapy;2021-02

4. Optimal time-points for detecting expression levels of BAALC, EVI1, and WT1 genes in patients with acute myeloid leukemia: a meta-analysis;Hematology;2021-01-01

5. Comparison of high-resolution melting analysis with direct sequencing for detection of FLT3-TKD, FLT3-ITD and WT1 mutations in acute myeloid leukemia;Cancer Treatment and Research Communications;2021